标题
Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-26
DOI
10.3389/fimmu.2018.00884
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulation of the Cell Biology of Antigen Cross-Presentation
- (2018) J. Magarian Blander Annual Review of Immunology
- CD8 + T Cells Orchestrate pDC-XCR1 + Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming
- (2017) Anna Brewitz et al. IMMUNITY
- Dendritic cell and antigen dispersal landscapes regulate T cell immunity
- (2017) Michael Y. Gerner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells
- (2017) Masashi Watanabe et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Structure of the human MHC-I peptide-loading complex
- (2017) Andreas Blees et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export
- (2017) Jeff E. Grotzke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines
- (2017) Eleni Maria Varypataki et al. Cancer Immunology Research
- PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
- (2017) Jan Willem Kleinovink et al. OncoImmunology
- The Optimization of Bioorthogonal Epitope Ligation within MHC-I Complexes
- (2016) Joanna B. Pawlak et al. ACS Chemical Biology
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination
- (2016) T. Ahrends et al. CANCER RESEARCH
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Dendritic cell maturation and cross-presentation: timing matters!
- (2016) Andrés Alloatti et al. IMMUNOLOGICAL REVIEWS
- Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles
- (2016) Eleni Maria Varypataki et al. JOURNAL OF CONTROLLED RELEASE
- Neoantigen landscape dynamics during human melanoma–T cell interactions
- (2016) Els M. E. Verdegaal et al. NATURE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- Detection of bioorthogonal groups by correlative light and electron microscopy allows imaging of degraded bacteria in phagocytes
- (2016) Daphne M. van Elsland et al. Chemical Science
- TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
- (2016) Gijs G. Zom et al. Oncotarget
- Bioorthogonal Deprotection on the Dendritic Cell Surface for Chemical Control of Antigen Cross-Presentation
- (2015) Joanna B. Pawlak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells
- (2015) Cynthia M Fehres et al. Cellular & Molecular Immunology
- Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens
- (2015) Andrés Alloatti et al. IMMUNITY
- Strategically Localized Dendritic Cells Promote Rapid T Cell Responses to Lymph-Borne Particulate Antigens
- (2015) Michael Y. Gerner et al. IMMUNITY
- Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation
- (2015) Sima Rahimian et al. JOURNAL OF CONTROLLED RELEASE
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways
- (2015) Mohammad Samie et al. NATURE IMMUNOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression
- (2015) T. C. van der Sluis et al. Cancer Immunology Research
- Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity
- (2014) Eleni Maria Varypataki et al. AAPS Journal
- Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
- (2014) T. C. van der Sluis et al. CLINICAL CANCER RESEARCH
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Presentation of Synthetic Long Peptides by Human Dendritic Cells: A Process Dependent on ERAD Component p97/VCP but Not sec61 and/or Derlin-1
- (2014) Jérémie Ménager et al. PLoS One
- Enhanced Cross-Presentation and Improved CD8+ T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice
- (2014) Judith Rauen et al. PLoS One
- Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
- (2014) G. G. Zom et al. Cancer Immunology Research
- Dendritic Cell-Targeted Vaccines
- (2014) Lillian Cohn et al. Frontiers in Immunology
- Recent Mechanistic Insights on Glycoconjugate Vaccines and Future Perspectives
- (2013) Francesco Berti et al. ACS Chemical Biology
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- CD141+ dendritic cells produce prominent amounts of IFN- after dsRNA recognition and can be targeted via DEC-205 in humanized mice
- (2013) S. Meixlsperger et al. BLOOD
- The ins-and-outs of endosomal antigens for cross-presentation
- (2013) Verena Schuette et al. CURRENT OPINION IN IMMUNOLOGY
- Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
- (2013) Rodney A. Rosalia et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes
- (2013) Lee Kim Swee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
- (2013) Ramon Arens et al. SEMINARS IN IMMUNOLOGY
- Skin-Resident Antigen-Presenting Cells: Instruction Manual for Vaccine Development
- (2013) Cynthia M. Fehres et al. Frontiers in Immunology
- Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells
- (2012) B. Chatterjee et al. BLOOD
- Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation
- (2012) A.L. Silva et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells
- (2012) Muzlifah Haniffa et al. IMMUNITY
- Targeting tumor antigens to dendritic cells using particulate carriers
- (2012) Medha D. Joshi et al. JOURNAL OF CONTROLLED RELEASE
- Tumor eradication by immunotherapy with biodegradable PLGA microspheres-an alternative to incomplete Freund's adjuvant
- (2011) Marc Mueller et al. INTERNATIONAL JOURNAL OF CANCER
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- ‘Dressed for success’ C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells
- (2010) Wendy WJ Unger et al. CURRENT OPINION IN IMMUNOLOGY
- Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
- (2009) Ellen M. Sletten et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+and CD4+T Cells
- (2009) Hongwei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori
- (2009) Sonja I Gringhuis et al. NATURE IMMUNOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity
- (2009) N. van Montfoort et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
- (2008) Martijn S. Bijker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma
- (2008) Jeffrey A. Sosman et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started